MA52933A - Composés inhibiteurs d'oga - Google Patents
Composés inhibiteurs d'ogaInfo
- Publication number
- MA52933A MA52933A MA052933A MA52933A MA52933A MA 52933 A MA52933 A MA 52933A MA 052933 A MA052933 A MA 052933A MA 52933 A MA52933 A MA 52933A MA 52933 A MA52933 A MA 52933A
- Authority
- MA
- Morocco
- Prior art keywords
- inhibitor compounds
- oga inhibitor
- oga
- compounds
- inhibitor
- Prior art date
Links
- 229940126137 O-GlcNAcase inhibitor Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18382446 | 2018-06-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA52933A true MA52933A (fr) | 2021-04-28 |
Family
ID=62784073
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA052933A MA52933A (fr) | 2018-06-20 | 2019-06-20 | Composés inhibiteurs d'oga |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20210261527A1 (fr) |
| EP (1) | EP3810592A1 (fr) |
| JP (1) | JP2021527668A (fr) |
| CN (1) | CN112313218A (fr) |
| AU (1) | AU2019289966A1 (fr) |
| CA (1) | CA3103910A1 (fr) |
| MA (1) | MA52933A (fr) |
| WO (1) | WO2019243525A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119971037A (zh) * | 2023-11-13 | 2025-05-13 | 上海交通大学医学院 | 靶向O-GlcNAc糖苷水解酶抑制剂促进髓鞘再生 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102884062B (zh) * | 2009-12-23 | 2016-08-03 | 嘉世高制药公司 | 氨基嘧啶激酶抑制剂 |
| SG11201701315VA (en) * | 2014-08-28 | 2017-03-30 | Asceneuron Sa | Glycosidase inhibitors |
| JP2019519582A (ja) * | 2016-06-29 | 2019-07-11 | オリオン コーポレーション | ベンゾジオキサン誘導体およびその医薬用途 |
| WO2018109202A1 (fr) * | 2016-12-16 | 2018-06-21 | Janssen Pharmaceutica Nv | Composés inhibiteurs d'oga monocyclique |
-
2019
- 2019-06-20 WO PCT/EP2019/066383 patent/WO2019243525A1/fr not_active Ceased
- 2019-06-20 MA MA052933A patent/MA52933A/fr unknown
- 2019-06-20 JP JP2020570730A patent/JP2021527668A/ja active Pending
- 2019-06-20 US US17/253,381 patent/US20210261527A1/en not_active Abandoned
- 2019-06-20 CA CA3103910A patent/CA3103910A1/fr not_active Abandoned
- 2019-06-20 EP EP19732985.7A patent/EP3810592A1/fr not_active Withdrawn
- 2019-06-20 CN CN201980041369.8A patent/CN112313218A/zh active Pending
- 2019-06-20 AU AU2019289966A patent/AU2019289966A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2019289966A1 (en) | 2020-12-17 |
| CA3103910A1 (fr) | 2019-12-26 |
| EP3810592A1 (fr) | 2021-04-28 |
| CN112313218A (zh) | 2021-02-02 |
| US20210261527A1 (en) | 2021-08-26 |
| WO2019243525A1 (fr) | 2019-12-26 |
| JP2021527668A (ja) | 2021-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA52939A (fr) | Composés inhibiteurs d'oga | |
| MA52942A (fr) | Composés inhibiteurs d'oga | |
| IL292753A (en) | Compounds | |
| MA47575A (fr) | Composés inhibiteurs d'oga monocyclique | |
| MA47420A (fr) | Composés inhibiteurs d'oga | |
| EP3836923A4 (fr) | Composés pyrrolo-dipyridine | |
| MA47576A (fr) | Composés inhibiteurs d'oga bicyclique | |
| EP3941898C0 (fr) | Composés fongicides | |
| MA52948A (fr) | Composés | |
| EP3737672A4 (fr) | Composés benzamide | |
| IL286833A (en) | Compositions containing brazzein | |
| MA51669A (fr) | Composés | |
| DK4083038T3 (da) | Pyridazinylthiazolcarboxamidforbindelse | |
| MA53003A (fr) | Composés | |
| EP3464275A4 (fr) | Composés inhibiteurs de l'egfr | |
| MA52004A (fr) | Inhibiteurs d'o-glycoprotéine-2-acétamido-2-désoxy-3-d-glycopyranosidase | |
| MA49006A (fr) | Inhibiteurs d'ip6k | |
| MA54521A (fr) | Dérivés d'oxopyridine substitués | |
| EP4077318A4 (fr) | Composés | |
| MA52946A (fr) | Composés | |
| EP3808747A4 (fr) | Composé d'imidazopyridinone | |
| EP3820980A4 (fr) | Compositions d'esterquats | |
| MA53648A (fr) | Inhibiteurs d'o-glycoprotéine-2-acétamido-2-désoxy-3-d-glucopyranosidase | |
| EP4003986A4 (fr) | Composés inhibiteurs | |
| LT3867247T (lt) | Naujieji junginiai |